1 year ago
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are cancers that affect lymphocytes. CLL and SLL are essentially the same diseases, with the only difference being the locati...
1 year ago
22 Days from Desperation to Rebirth! Chinese CAR-T Therapy Creates Survival Miracle for Thai Multiple Myeloma Patient Patient story In July 2017, 58-year-old Ms. M was diagnosed with multiple mye...
1 year ago
🎗️ **Participants in China’s CAR-T ‘Lymphoma Value-Based Payment Plan’ have achieved complete remission.** 🎗️ Lymphoma Exciting news! Fosun Kite has just announced that the first...
1 year ago
Axicabtagene Ciloleucel Package Insert INDICATIONS 1. Adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell ly...
1 year ago
Axicabtagene Ciloleucel Mechanism of Action Introduction In the evolving landscape of cancer treatment, Axicabtagene Ciloleucel (Axi-cel) has emerged as a groundbreaking therapy, offering patients ...
1 year ago
Axicabtagene Ciloleucel Follicular Lymphoma: Revolutionizing Cancer Care with Personalized Immunotherapy Follicular lymphoma is a type of non-Hodgkin’s lymphoma that affects the lymphatic sys...
1 year ago
On December 21, 2023, Kite Announced Axicabtagene Ciloleucel FDA Label Update, Incorporating the Pivotal Phase 3 ZUMA-7 Study’s Overall Survival (OS) Analysis On December 21, 2023, Kite, a Gi...
1 year ago
March 5, 2021 Axicabtagene Ciloleucel FDA Approval for Adult Patients with Relapsed or Refractory Follicular Lymphoma (FL) after two or More Systemic Treatments On March 5, 2021, the U.S. Food and ...
1 year ago
### 🚀 The Chinese medical team’s Revolutionary CAR-T Therapy: Long-lasting asthma relief with a single injection.! asthma 📢 Exciting news from the world of medical science! The team led by Pr...
1 year ago
September 28, 2022 Axicabtagene Ciloleucel (Yescarta) EMA Approval for B-cell Lymphoma Patients After First-Line Treatment Yescarta Approved in Europe for B-Cell Lymphoma On September 28, 2022, the...
1 year ago
Yescarta Follicular Lymphoma EMA Approved the Listing on June 28, 2022 Yescarta Approved in the European Union for Follicular Lymphoma On June 28, 2022, local time, Gilead’s cell therapy comp...
1 year ago
**Заголовок: Ключевые этапы прецизионного лечения: подробный обзор инфузии CAR-T у российского пациента в шанхайской больнице Jiahui** https://www.medtourcn.com/wp-content/uploads/2024/06/俄罗斯患...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
